跳至主要内容
临床试验/JPRN-UMIN000053234
JPRN-UMIN000053234尚未招募Unknown

Short-term weight loss and body composition changes in patients with obesity by GLP-1 and GIP/GLP-1 receptor agonists in combination with low-calorie diet. - Short-term therapeutic effects of GLP-1 and GIP/GLP-1 receptor agonists on patients with obesity during severe energy restriction.

Kimitsu Chuo Hospital0 个研究点目标入组 40 人开始时间: 2023年12月31日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) Patients who were or plan to be pregnant. (2) Patients who were unable to cooperate with treatment due to mental illness or language barrier. (3) Patients with a history of GLP-1 receptor agonist use other than oral and subcutaneous semaglutide and tirzepatide. (4) Patients who failed to continue GLP-1 or GIP/GLP-1 receptor agonists during hospitalization. (5) Patients who were unable to continue the LCD provided by our hospital. (6) Other patients deemed inappropriate as research subjects by the principal investigator.

研究者

发起方
Kimitsu Chuo Hospital

相似试验